THERAPEUTIC DRUG MONITORING IN THE TREATMENT OF EPILEPSY
Introducing the therapeutic drug monitoring of valproic acids can reduce the economic burden of epilepsy; thus this is a clinically justified and pharmacoeconomic aspect of therapeutic management of the above disease.